查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1904627

2032年医学影像和放射技术进步市场预测：按模式、技术、应用、最终用户和地区分類的全球分析

Medical Imaging & Radiology Advances Market Forecasts to 2032 - Global Analysis By Modality, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，预计到 2025 年，全球医学影像和放射学进步市场规模将达到 438 亿美元，到 2032 年将达到 628.8 亿美元，预测期内复合年增长率为 5.3%。

医学影像和放射学的进步是指开发和应用各种技术来视觉化人体内部结构和功能，以用于诊断、治疗计划和疾病监测。此领域涵盖的影像方式包括X光、CT（电脑断层扫描）、MRI（磁振造影）、超音波、PET（正子断层扫描）和核子医学影像等。这些进步主要集中在提高影像解析度、降低辐射暴露、提高诊断准确性以及实现即时成像等方面。人工智慧、3D影像和微创手术的整合进一步优化了患者照护，有助于疾病的早期发现，并促进在各种医疗环境中实施个人化治疗策略。

慢性疾病负担日益加重

癌症、心血管疾病和神经系统疾病等慢性病的日益普遍，推动了对先进医学影像和放射学解决方案的需求。早期准确诊断在疾病管理和治疗方案製定中发挥至关重要的作用，促使医疗机构采用尖端成像技术。随着人口老化和文明病的增加，对精准、非侵入性诊断方法的需求日益增长，而医学影像技术的进步正逐渐成为改善患者预后和降低长期医疗成本的重要工具。

高成本

先进医学影像技术的应用受到设备购置、安装和持续维护所需巨额资本投入的限制。高昂的营运成本，包括校准、软体更新和专业人员人员编制，进一步限制了市场发展，尤其是在发展中地区。儘管临床效益显着，但小规模的医疗机构往往难以证明这些支出的合理性。因此，成本因素限制了技术的广泛应用，减缓了其普及速度，并为製造商和医疗服务提供者带来了严峻挑战。

技术进步

持续的技术创新为该领域创造了巨大的成长机会。人工智慧 (AI)、机器学习和 3D 成像技术的融合，提高了诊断准确率，缩短了解读时间，并实现了个人化治疗方案的发展。此外，低剂量辐射技术、携带式成像设备和微创手术的发展，拓展了临床应用范围。这些进步使医疗服务提供者能够提供更精准、高效、以患者为中心的服务，并将技术打造为市场扩张的关键驱动力。

监理和合规挑战

严格的法规结构和合规要求给市场带来了持续的挑战。製造商必须应对全球各地卫生监管机构制定的复杂核准流程、品质标准和安全通讯协定。监管审批的延误会阻碍产品上市，增加研发成本并限制市场进入。此外，不断变化的病患资料隐私和辐射安全指南也需要持续监测和调整。这些因素会造成营运和财务压力，并可能减缓创新步伐。

新冠疫情的影响

新冠疫情对医学影像和放射学市场产生了双重影响。初期，非紧急影像检查被推迟，导致市场活动暂时减少。然而，乳房摄影筛检，特别是X光和电脑断层扫描，需求激增，用于诊断新冠肺炎和监测肺部併发症。疫情也加速了远距放射学和基于人工智慧的诊断工具的应用，以最大限度地减少患者接触并提高工作流程效率。总而言之，新冠疫情凸显了先进影像技术在未来投资和技术应用策略中将扮演的重要角色。

预计在预测期内，核医影像领域将占据最大的市场份额。

由于核医学影像在检测和后续观察包括癌症和神经系统疾病在内的复杂疾病方面发挥着至关重要的作用，预计在预测期内，核医学影像领域将占据最大的市场份额。 PET 和 SPECT 等核医学影像技术能够提供高度灵敏的功能讯息，是解剖成像的强大补充。放射性药物的持续创新和剂量优化进一步提升了其临床效用。全球医院和诊断中心对这些技术的日益普及，以及人们对早期疾病检测益处的认识不断提高，正在推动市场需求的持续成长。

预计在预测期内，诊断中心细分市场将呈现最高的复合年增长率。

预计在预测期内，诊断中心领域将实现最高成长率，因为这些中心能够在一个屋檐下提供多种影像检查方式，从而实现高效的诊断和后续观察。不断提高的健康意识、对门诊就医的偏好以及经济实惠的服务，都促进了患者群体的扩大。此外，与医院的合作以及远距放射学的整合，使得影像分析和报告能够快速进行。因此，诊断中心正在成为先进影像技术和市场成长的关键枢纽。

比最大的地区

由于患者对早期诊断的意识提升不断提高，亚太地区预计将在预测期内保持最大的市场份额。私人医疗机构的扩张和政府为改善医疗服务所采取的倡议，都促进了市场渗透。快速的都市化、可支配收入的成长以及保险覆盖范围的扩大，进一步推动了先进成像技术的应用。此外，对培养专业放射科医生和建立诊断中心的投资，增强了该地区实施尖端影像解决方案的能力，从而巩固了其作为主要市场贡献者的地位。

复合年均成长率最高的地区

在预测期内，北美地区预计将实现最高的复合年增长率，这得益于其先进的基础设施、健全的医保政策和强劲的倡议。对精准医疗、疾病早期检测和微创手术的日益重视，正在推动下一代影像技术的应用。此外，完善的诊断网络和对创新技术的监管支持，也促进了技术的快速商业化，使北美成为全球医学影像放射学领域的重要成长中心。

关于免费客製化服务

购买此报告的客户可享有以下免费自订选项之一：

  • 公司概况
    • 最多三家新增市场参与企业进行全面分析
    • 主要企业SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户要求，对主要国家进行市场估算和预测，并计算复合年增长率（註：可行性需确认）。
  • 竞争标竿分析
    • 从产品系列、地域覆盖范围和策略联盟等方面对主要参与企业进行基准分析

目录

第一章执行摘要

第二章 前言

  • 摘要
  • 相关利益者
  • 调查范围
  • 调查方法
  • 研究材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球医学影像和放射技术进步市场（按模式划分）

  • X射线影像
    • 数位X光
    • 可携式X光机
    • 模拟X射线
  • 超音波成像
    • 二维超音波
    • 多普勒超音波
    • 3D/4D超音波
  • 磁振造影（MRI）
    • 低场磁振造影
    • 高场磁振造影
    • 中场磁振造影
  • 电脑断层扫描（CT）
  • 核子医学影像
  • 其他方式

6. 全球医学影像与放射技术进步市场

  • 影像处理中的人工智慧
  • 基于云端的成像解决方案
  • 3D和4D成像
  • 可携式和照护现场成像
  • 混合影像（PET/CT、PET/MRI）

7. 全球医学影像和放射技术进步市场（按应用领域划分）

  • 诊断影像
  • 治疗性介入影像
  • 研究和临床试验

8. 全球医学影像和放射技术进步市场（按最终用户划分）

  • 医院
  • 研究所
  • 诊断中心
  • 门诊手术中心

9. 全球医疗影像和放射技术进步市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：重大进展

  • 协议、伙伴关係、合作和合资企业
  • 併购
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十一章 企业概况

  • GE HealthCare
  • Agfa Gevaert Group
  • Siemens Healthineers
  • Mindray Medical International Limited
  • Philips Healthcare
  • Neusoft Medical Systems Co., Ltd.
  • Canon Medical Systems Corporation
  • Carestream Health
  • Fujifilm Holdings Corporation
  • Konica Minolta Healthcare
  • Hologic, Inc.
  • Bracco Imaging
  • Hitachi Medical Systems
  • Esaote SpA
  • Samsung Medison
Product Code: SMRC32991

According to Stratistics MRC, the Global Medical Imaging & Radiology Advances Market is accounted for $43.80 billion in 2025 and is expected to reach $62.88 billion by 2032 growing at a CAGR of 5.3% during the forecast period. Medical imaging and radiology advances encompass the development and application of technologies that visualize the internal structures and functions of the body for diagnosis, treatment planning, and monitoring of diseases. This field includes modalities such as X-ray, CT (computed tomography), MRI (magnetic resonance imaging), ultrasound, PET (positron emission tomography), and nuclear imaging. Advances focus on improving image resolution, reducing radiation exposure, enhancing diagnostic accuracy, and enabling real-time imaging. Integration with artificial intelligence, 3D imaging, and minimally invasive procedures further optimizes patient care, supports early disease detection, and facilitates personalized treatment strategies across healthcare settings.

Market Dynamics:

Driver:

Increasing Burden of Chronic Diseases

The rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is fueling the demand for advanced medical imaging and radiology solutions. Early and accurate diagnosis plays a critical role in disease management and treatment planning, driving healthcare providers to adopt cutting-edge imaging technologies. As population's age and lifestyle-related disorders increase, the need for precise, non-invasive diagnostic modalities grows, positioning medical imaging advances as essential tools for improving patient outcomes and reducing long-term healthcare costs.

Restraint:

High Cost of Equipment & Maintenance

The adoption of advanced medical imaging technologies is hindered by the substantial capital investment required for equipment procurement, installation, and ongoing maintenance. High operational costs, including calibration, software updates, and specialized staffing, further constrain the market, particularly in developing regions. Smaller healthcare facilities often struggle to justify these expenditures despite the clinical benefits. Consequently, cost considerations limit widespread accessibility, slowing the pace of adoption and presenting a significant challenge for manufacturers and healthcare providers.

Opportunity:

Advancements in technology

Continuous technological innovation presents significant growth opportunities within the sector. Integration of artificial intelligence, machine learning, and 3D imaging enhances diagnostic accuracy, reduces interpretation time, and enables personalized treatment planning. Moreover, developments in low-dose radiation techniques, portable imaging devices, and minimally invasive procedures expand clinical applications. These advancements allow healthcare providers to deliver more precise, efficient, and patient-friendly services, positioning technology as a pivotal driver for market expansion.

Threat:

Regulatory & Compliance Challenges

Stringent regulatory frameworks and compliance requirements pose ongoing challenges for the market. Manufacturers must navigate complex approvals, quality standards, and safety protocols imposed by global health authorities. Delays in regulatory clearance can hinder product launches, increase development costs, and limit market entry. Additionally, evolving guidelines around patient data privacy and radiation safety necessitate continuous monitoring and adaptation. These factors create operational and financial pressures, potentially slowing innovation.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the medical imaging and radiology market. Initially, non-essential imaging procedures were postponed, temporarily reducing market activity. However, demand for chest imaging, particularly X-rays and CT scans, surged for COVID-19 diagnosis and monitoring of pulmonary complications. The pandemic accelerated the adoption of tele-radiology and AI-based diagnostic tools to minimize patient contact and enhance workflow efficiency. Overall, COVID-19 highlighted the critical role of advanced imaging shaping future investment and technology deployment strategies.

The nuclear imaging segment is expected to be the largest during the forecast period

The nuclear imaging segment is expected to account for the largest market share during the forecast period, due to its critical role in detecting and monitoring complex diseases, including cancer and neurological conditions. Nuclear imaging techniques, such as PET and SPECT, provide highly sensitive functional information that complements anatomical imaging. Continuous innovations in radiopharmaceuticals and dose optimization have further enhanced clinical utility. Growing adoption in hospitals and diagnostic centers globally, coupled with increasing awareness of early disease detection benefits, drives sustained demand.

The diagnostic centers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the diagnostic centers segment is predicted to witness the highest growth rate, as these centers offer a wide range of imaging modalities under one roof, facilitating efficient diagnosis and follow-up care. Rising health awareness, outpatient care preference, and cost-effective services contribute to the expanding patient base. Additionally, partnerships with hospitals and tele-radiology integration enable rapid image analysis and reporting. Consequently, diagnostic centers are emerging as critical hubs for advanced imaging adoption and market growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to growing patient awareness of early diagnosis. Expanding private healthcare facilities and government initiatives to enhance medical services contribute to market penetration. Rapid urbanization, higher disposable incomes, and improved insurance coverage further support adoption of advanced imaging technologies. Moreover, investments in training skilled radiologists and establishing diagnostic centers strengthen the region's capacity to implement cutting-edge imaging solutions, consolidating its position as a leading market contributor.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to region benefits from advanced infrastructure, robust reimbursement policies, and strong research and development initiatives. Increased focus on precision medicine, early disease detection, and minimally invasive procedures encourages integration of next-generation imaging modalities. Additionally, well-established diagnostic networks and regulatory support for innovative technologies facilitate rapid commercialization, making North America a key growth hotspot in the global medical imaging and radiology advances.

Key players in the market

Some of the key players in Medical Imaging & Radiology Advances Market include GE HealthCare, Agfa-Gevaert Group, Siemens Healthineers, Mindray Medical International Limited, Philips Healthcare, Neusoft Medical Systems Co., Ltd., Canon Medical Systems Corporation, Carestream Health, Fujifilm Holdings Corporation, Konica Minolta Healthcare, Hologic, Inc., Bracco Imaging, Hitachi Medical Systems, Esaote SpA and Samsung Medison.

Key Developments:

In November 2025, Siemens Healthineers introduced Syngo Carbon 2.0, an upgraded enterprise imaging platform. The launch integrates multimodal imaging data, AI-powered workflow automation, and cloud-based collaboration, designed to streamline radiology operations and improve diagnostic accuracy across global healthcare systems.

In October 2025, Siemens Healthineers expanded its collaboration with Varian and multiple oncology centers to accelerate precision therapy solutions. The joint venture integrates imaging, radiation therapy, and AI-driven planning tools, aiming to improve cancer treatment outcomes and strengthen Siemens' leadership in oncology care.

Modalities Covered:

  • X-Ray Imaging
  • Ultrasound Imaging
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Nuclear Imaging
  • Other Modalities

Technologies Covered:

  • Artificial Intelligence in Imaging
  • Cloud-based Imaging Solutions
  • 3D & 4D Imaging
  • Portable & Point-of-Care Imaging
  • Hybrid Imaging (PET/CT, PET/MRI)

Applications Covered:

  • Diagnostic Imaging
  • Therapeutic/Interventional Imaging
  • Research & Clinical Trials

End Users Covered:

  • Hospitals
  • Research Institutes
  • Diagnostic Centers
  • Ambulatory Surgical Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Medical Imaging & Radiology Advances Market, By Modality

  • 5.1 Introduction
  • 5.2 X-Ray Imaging
    • 5.2.1 Digital X-Ray
    • 5.2.2 Portable X-Ray
    • 5.2.3 Analog X-Ray
  • 5.3 Ultrasound Imaging
    • 5.3.1 2D Ultrasound
    • 5.3.2 Doppler Ultrasound
    • 5.3.3 3D/4D Ultrasound
  • 5.4 Magnetic Resonance Imaging (MRI)
    • 5.4.1 Low-field MRI
    • 5.4.2 High-field MRI
    • 5.4.3 Mid-field MRI
  • 5.5 Computed Tomography (CT)
  • 5.6 Nuclear Imaging
  • 5.7 Other Modalities

6 Global Medical Imaging & Radiology Advances Market, By Technology

  • 6.1 Introduction
  • 6.2 Artificial Intelligence in Imaging
  • 6.3 Cloud-based Imaging Solutions
  • 6.4 3D & 4D Imaging
  • 6.5 Portable & Point-of-Care Imaging
  • 6.6 Hybrid Imaging (PET/CT, PET/MRI)

7 Global Medical Imaging & Radiology Advances Market, By Application

  • 7.1 Introduction
  • 7.2 Diagnostic Imaging
  • 7.3 Therapeutic/Interventional Imaging
  • 7.4 Research & Clinical Trials

8 Global Medical Imaging & Radiology Advances Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Research Institutes
  • 8.4 Diagnostic Centers
  • 8.5 Ambulatory Surgical Centers

9 Global Medical Imaging & Radiology Advances Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 GE HealthCare
  • 11.2 Agfa Gevaert Group
  • 11.3 Siemens Healthineers
  • 11.4 Mindray Medical International Limited
  • 11.5 Philips Healthcare
  • 11.6 Neusoft Medical Systems Co., Ltd.
  • 11.7 Canon Medical Systems Corporation
  • 11.8 Carestream Health
  • 11.9 Fujifilm Holdings Corporation
  • 11.10 Konica Minolta Healthcare
  • 11.11 Hologic, Inc.
  • 11.12 Bracco Imaging
  • 11.13 Hitachi Medical Systems
  • 11.14 Esaote SpA
  • 11.15 Samsung Medison

List of Tables

  • Table 1 Global Medical Imaging & Radiology Advances Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Medical Imaging & Radiology Advances Market Outlook, By Modality (2024-2032) ($MN)
  • Table 3 Global Medical Imaging & Radiology Advances Market Outlook, By X-Ray Imaging (2024-2032) ($MN)
  • Table 4 Global Medical Imaging & Radiology Advances Market Outlook, By Digital X-Ray (2024-2032) ($MN)
  • Table 5 Global Medical Imaging & Radiology Advances Market Outlook, By Portable X-Ray (2024-2032) ($MN)
  • Table 6 Global Medical Imaging & Radiology Advances Market Outlook, By Analog X-Ray (2024-2032) ($MN)
  • Table 7 Global Medical Imaging & Radiology Advances Market Outlook, By Ultrasound Imaging (2024-2032) ($MN)
  • Table 8 Global Medical Imaging & Radiology Advances Market Outlook, By 2D Ultrasound (2024-2032) ($MN)
  • Table 9 Global Medical Imaging & Radiology Advances Market Outlook, By Doppler Ultrasound (2024-2032) ($MN)
  • Table 10 Global Medical Imaging & Radiology Advances Market Outlook, By 3D/4D Ultrasound (2024-2032) ($MN)
  • Table 11 Global Medical Imaging & Radiology Advances Market Outlook, By Magnetic Resonance Imaging (MRI) (2024-2032) ($MN)
  • Table 12 Global Medical Imaging & Radiology Advances Market Outlook, By Low-field MRI (2024-2032) ($MN)
  • Table 13 Global Medical Imaging & Radiology Advances Market Outlook, By High-field MRI (2024-2032) ($MN)
  • Table 14 Global Medical Imaging & Radiology Advances Market Outlook, By Mid-field MRI (2024-2032) ($MN)
  • Table 15 Global Medical Imaging & Radiology Advances Market Outlook, By Computed Tomography (CT) (2024-2032) ($MN)
  • Table 16 Global Medical Imaging & Radiology Advances Market Outlook, By Nuclear Imaging (2024-2032) ($MN)
  • Table 17 Global Medical Imaging & Radiology Advances Market Outlook, By Other Modalities (2024-2032) ($MN)
  • Table 18 Global Medical Imaging & Radiology Advances Market Outlook, By Technology (2024-2032) ($MN)
  • Table 19 Global Medical Imaging & Radiology Advances Market Outlook, By Artificial Intelligence in Imaging (2024-2032) ($MN)
  • Table 20 Global Medical Imaging & Radiology Advances Market Outlook, By Cloud-based Imaging Solutions (2024-2032) ($MN)
  • Table 21 Global Medical Imaging & Radiology Advances Market Outlook, By 3D & 4D Imaging (2024-2032) ($MN)
  • Table 22 Global Medical Imaging & Radiology Advances Market Outlook, By Portable & Point-of-Care Imaging (2024-2032) ($MN)
  • Table 23 Global Medical Imaging & Radiology Advances Market Outlook, By Hybrid Imaging (PET/CT, PET/MRI) (2024-2032) ($MN)
  • Table 24 Global Medical Imaging & Radiology Advances Market Outlook, By Application (2024-2032) ($MN)
  • Table 25 Global Medical Imaging & Radiology Advances Market Outlook, By Diagnostic Imaging (2024-2032) ($MN)
  • Table 26 Global Medical Imaging & Radiology Advances Market Outlook, By Therapeutic/Interventional Imaging (2024-2032) ($MN)
  • Table 27 Global Medical Imaging & Radiology Advances Market Outlook, By Research & Clinical Trials (2024-2032) ($MN)
  • Table 28 Global Medical Imaging & Radiology Advances Market Outlook, By End User (2024-2032) ($MN)
  • Table 29 Global Medical Imaging & Radiology Advances Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 30 Global Medical Imaging & Radiology Advances Market Outlook, By Research Institutes (2024-2032) ($MN)
  • Table 31 Global Medical Imaging & Radiology Advances Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
  • Table 32 Global Medical Imaging & Radiology Advances Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.